相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TMEM173 variants and potential importance to human biology and disease
Seema Patel et al.
GENES AND IMMUNITY (2019)
Autophagic cell death restricts chromosomal instability during replicative crisis
Joe Nassour et al.
NATURE (2019)
Trojan horses for immunotherapy
Jeffrey A. Hubbell et al.
NATURE NANOTECHNOLOGY (2019)
An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer
Xiang An et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
Daniel Shae et al.
NATURE NANOTECHNOLOGY (2019)
Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells
Jeonghyun Ahn et al.
CANCER CELL (2018)
Myeloid cell heterogeneity in cancer: not a single cell alike
Mate Kiss et al.
CELLULAR IMMUNOLOGY (2018)
Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma
Jun S. Wei et al.
CLINICAL CANCER RESEARCH (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Can innate immune system targets turn up the heat on 'cold' tumours?
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Photothermal Therapy Generates a Thermal Window of Immunogenic Cell Death in Neuroblastoma
Elizabeth E. Sweeney et al.
SMALL (2018)
CAR-T cells: the long and winding road to solid tumors
Maria Michela D'Aloia et al.
CELL DEATH & DISEASE (2018)
Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites
Zachary S. Morris et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
Irina V. Kholodenko et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
A. Marabelle et al.
ANNALS OF ONCOLOGY (2018)
Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
Kelsey E. Sivick et al.
CELL REPORTS (2018)
CAR T Cell Therapy for Neuroblastoma
Rebecca M. Richards et al.
FRONTIERS IN IMMUNOLOGY (2018)
Enhancing immunotherapy of STING agonist for lymphoma in preclinical models
Adrienne Sallets et al.
BLOOD ADVANCES (2018)
A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer
Ning Cheng et al.
JCI INSIGHT (2018)
STING Signaling in Cancer Cells: Important or Not?
Olga Sokolowska et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)
Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
Bridget Larkin et al.
JOURNAL OF IMMUNOLOGY (2017)
Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors
Atif A. Ahmed et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2017)
cGAS is essential for the antitumor effect of immune checkpoint blockade
Hua Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
Lars M. Wagner et al.
ONCOTARGETS AND THERAPY (2017)
Signalling strength determines proapoptotic functions of STING
Muhammet F. Gulen et al.
NATURE COMMUNICATIONS (2017)
Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
Casey R. Ager et al.
CANCER IMMUNOLOGY RESEARCH (2017)
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
Jeremy B. Foote et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression
Julian P. Layer et al.
ONCOIMMUNOLOGY (2017)
Assessment of Programmed Death-Ligand 1 Expression and Tumor-Associated Immune Cells in Pediatric Cancer Tissues
Robbie G. Majzner et al.
CANCER (2017)
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site
Takayuki Ohkuri et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Delivering safer immunotherapies for cancer
Lauren Milling et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway
Suruchi N. Schock et al.
CELL DEATH AND DIFFERENTIATION (2017)
Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy
Sandeep T. Koshy et al.
ADVANCED BIOSYSTEMS (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
Melinda S. Merchant et al.
CLINICAL CANCER RESEARCH (2016)
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance
Alessandra Dondero et al.
ONCOIMMUNOLOGY (2016)
The host STING pathway at the interface of cancer and immunity
Leticia Corrales et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan et al.
NATURE MEDICINE (2016)
Low Frequency of Programmed Death Ligand 1 Expression in Pediatric Cancers
Takahiro Aoki et al.
PEDIATRIC BLOOD & CANCER (2016)
STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia
Emily Curran et al.
CELL REPORTS (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity
Francis Mussai et al.
CANCER RESEARCH (2015)
Nanoparticu late STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C. Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
Olivier Demaria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma
Marco Mina et al.
ONCOIMMUNOLOGY (2015)
Intratumoral Immunization: A New Paradigm for Cancer Therapy
Aurelien Marabelle et al.
CLINICAL CANCER RESEARCH (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma
Michiel Kroesen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the Hu14.18 antibody increases intratumoral CD8+T and NK cells and improves survival
Richard K. Yang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Turning Tumors into Vaccines: Co-opting the Innate Immune System
Jasper G. van den Boorn et al.
IMMUNITY (2013)
The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes
Lena-Maria Carlson et al.
ONCOIMMUNOLOGY (2013)
Immunosuppressive microenvironment in neuroblastoma
Vito Pistoia et al.
FRONTIERS IN ONCOLOGY (2013)
New Strategies in Refractory and Recurrent Neuroblastoma: Translational Opportunities to Impact Patient Outcome
Kristina A. Cole et al.
CLINICAL CANCER RESEARCH (2012)
Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
Shahab Asgharzadeh et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
Ilia N. Buhtoiarov et al.
IMMUNOLOGY (2011)
Targeting Toll-like receptors: emerging therapeutics?
Elizabeth J. Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma
Suzanne A. Miles et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo
Ebba Paimberg et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The tumor-draining lymph node as an immune-privileged site
David H. Munn et al.
IMMUNOLOGICAL REVIEWS (2006)
Plasmacytoid dendritic cells: The key to CpG
S Rothenfusser et al.
HUMAN IMMUNOLOGY (2002)
分享论文
